首页> 外文会议>Society for biomaterials annual meeting and exposition >Biomaterials and biotechnology: From the discovery of the first angiogenesis inhibitors to the development of controlled drug delivery systems and the foundation of tissue engineering
【24h】

Biomaterials and biotechnology: From the discovery of the first angiogenesis inhibitors to the development of controlled drug delivery systems and the foundation of tissue engineering

机译:生物材料和生物技术:从第一次血管生成抑制剂的发现到受控药物递送系统的发展和组织工程的基础

获取原文

摘要

Advanced drug delivery systems are having an enormous impact on human health. We start by discussing our early research on developing the first controlled release systems for macromolecules and the isolation of angiogenesis inhibitors and how these led to numerous new therapies. For example, new drug delivery technologies including nanoparticles and nanotechnology are now being studied for use treating cancer and other illnesses. We then discuss ways of developing novel microchips for drug delivery. Approaches for creating new biomaterials are then evaluated and examples where such materials are used in brain cancer and shape memory applications are discussed. Finally, by combining mammalian cells, including stem cells, with synthetic polymers, new approaches for engineering tissues are being developed that may someday help in various disease. Examples in the areas of cartilage, skin, blood vessels and spinal cord repair are discussed.
机译:高级药物递送系统对人类健康产生巨大影响。我们首先讨论我们的早期研究,开发用于大分子的第一控释放系统以及血管生成抑制剂的分离以及这些新的新疗法。例如,现在正在研究包括纳米颗粒和纳米技术的新药递送技术,用于治疗癌症和其他疾病。然后,我们讨论开发新型微芯片进行药物递送的方法。然后评估制造新生物材料的方法,并讨论了这些材料在脑癌中使用的实施例,并且是脑癌和形状存储器应用的实例。最后,通过将包括干细胞的哺乳动物细胞组合,具有合成聚合物,正在开发出一种工程组织的新方法,可能有一天有一定有助于各种疾病。讨论了软骨,皮肤,血管和脊髓修复区域的实例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号